Eugenia Negredo

Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study

M. Larrousse, S. Arterburn, P. Ferrer, 2013, HIV medicine.

2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0

O. Kirk, A. Wensing, A. Winston, 2020, HIV medicine.

Differential Subcutaneous Adipose Tissue Gene Expression Patterns in a Randomized Clinical Trial of Efavirenz or Lopinavir-Ritonavir in Antiretroviral-Naive Patients

E. Negredo, M. Arnedo, E. Martinez, 2014, Antimicrobial Agents and Chemotherapy.

Variable endothelial cell function restoration after initiation of two antiretroviral regimens in HIV-infected individuals

B. Clotet, A. Bayés‐Genís, E. Negredo, 2017, The Journal of antimicrobial chemotherapy.

Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study).

B. Clotet, E. Negredo, R. Lopez-Blazquez, 2010, Antiviral research.